380 related articles for article (PubMed ID: 35473827)
1. The impact of shifting demographics, variants of concern and vaccination on outcomes during the first 3 COVID-19 waves in Alberta and Ontario: a retrospective cohort study.
McAlister FA; Nabipoor M; Chu A; Lee DS; Saxinger L; Bakal JA;
CMAJ Open; 2022; 10(2):E400-E408. PubMed ID: 35473827
[TBL] [Abstract][Full Text] [Related]
2. Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar.
Butt AA; Dargham SR; Chemaitelly H; Al Khal A; Tang P; Hasan MR; Coyle PV; Thomas AG; Borham AM; Concepcion EG; Kaleeckal AH; Latif AN; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
JAMA Intern Med; 2022 Feb; 182(2):197-205. PubMed ID: 34935861
[TBL] [Abstract][Full Text] [Related]
3. Outcomes Among Patients Hospitalized With Non-COVID-19 Conditions Before and During the COVID-19 Pandemic in Alberta and Ontario, Canada.
McAlister FA; Chu A; Qiu F; Dong Y; van Diepen S; Youngson E; Yu AYX; de Mestral C; Ross HJ; Austin PC; Lee DS; Kadri SS; Wijeysundera HC;
JAMA Netw Open; 2023 Jul; 6(7):e2323035. PubMed ID: 37436751
[TBL] [Abstract][Full Text] [Related]
4. Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves.
Birol Ilter P; Prasad S; Mutlu MA; Tekin AB; O'Brien P; von Dadelszen P; Magee LA; Tekin S; Tug N; Kalafat E; Khalil A
Ultrasound Obstet Gynecol; 2022 Jul; 60(1):96-102. PubMed ID: 35441407
[TBL] [Abstract][Full Text] [Related]
5. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
Ali AM; Tofiq AM; Rostam HM; Ali KM; Tawfeeq HM
J Med Virol; 2022 Dec; 94(12):5867-5876. PubMed ID: 36029103
[TBL] [Abstract][Full Text] [Related]
6. A cohort study of patients hospitalised with SARS-CoV-2 infection in Ontario: patient characteristics and outcomes by wave.
Habbous S; Lambrinos A; Ming K; Hellsten E
Swiss Med Wkly; 2024 Mar; 154():3636. PubMed ID: 38579312
[TBL] [Abstract][Full Text] [Related]
7. Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
Gram MA; Emborg HD; Schelde AB; Friis NU; Nielsen KF; Moustsen-Helms IR; Legarth R; Lam JUH; Chaine M; Malik AZ; Rasmussen M; Fonager J; Sieber RN; Stegger M; Ethelberg S; Valentiner-Branth P; Hansen CH
PLoS Med; 2022 Sep; 19(9):e1003992. PubMed ID: 36048766
[TBL] [Abstract][Full Text] [Related]
8. Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study.
Hesni E; Sayad B; Khosravi Shadmani F; Najafi F; Khodarahmi R; Rahimi Z; Bozorgomid A; Sayad N
BMC Infect Dis; 2022 Mar; 22(1):319. PubMed ID: 35361161
[TBL] [Abstract][Full Text] [Related]
9. Statins and SARS-CoV-2 Infection: Results of a Population-Based Prospective Cohort Study of 469 749 Adults From 2 Canadian Provinces.
McAlister FA; Wang T; Wang X; Chu A; Goodman SG; van Diepen S; Jackevicius CA; Kaul P; Udell J; Ko DT; Kwong JC; Austin PC; Lee DS;
J Am Heart Assoc; 2021 Nov; 10(21):e022330. PubMed ID: 34689613
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 Recovery Patterns Across Alpha (B.1.1.7) and Delta (B.1.617.2) Variants of SARS-CoV-2.
Kumar N; Quadri S; AlAwadhi AI; AlQahtani M
Front Immunol; 2022; 13():812606. PubMed ID: 35237265
[TBL] [Abstract][Full Text] [Related]
11. The risk of death or unplanned readmission after discharge from a COVID-19 hospitalization in Alberta and Ontario.
McAlister FA; Dong Y; Chu A; Wang X; Youngson E; Quinn KL; Verma A; Udell JA; Yu AYX; Razak F; Ho C; de Mestral C; Ross HJ; van Walraven C; Lee DS;
CMAJ; 2022 May; 194(19):E666-E673. PubMed ID: 35577377
[TBL] [Abstract][Full Text] [Related]
12. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.
Twohig KA; Nyberg T; Zaidi A; Thelwall S; Sinnathamby MA; Aliabadi S; Seaman SR; Harris RJ; Hope R; Lopez-Bernal J; Gallagher E; Charlett A; De Angelis D; Presanis AM; Dabrera G;
Lancet Infect Dis; 2022 Jan; 22(1):35-42. PubMed ID: 34461056
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the relative virulence of novel SARS-CoV-2 variants: a retrospective cohort study in Ontario, Canada.
Fisman DN; Tuite AR
CMAJ; 2021 Oct; 193(42):E1619-E1625. PubMed ID: 34610919
[TBL] [Abstract][Full Text] [Related]
14. Testing, infection and complication rates of COVID-19 among people with a recent history of homelessness in Ontario, Canada: a retrospective cohort study.
Richard L; Booth R; Rayner J; Clemens KK; Forchuk C; Shariff SZ
CMAJ Open; 2021; 9(1):E1-E9. PubMed ID: 33436450
[TBL] [Abstract][Full Text] [Related]
15. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
[TBL] [Abstract][Full Text] [Related]
16. Relative Virulence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Vaccinated and Unvaccinated Individuals Hospitalized With SARS-CoV-2.
Grima AA; Murison KR; Simmons AE; Tuite AR; Fisman DN
Clin Infect Dis; 2023 Feb; 76(3):e409-e415. PubMed ID: 35616115
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses.
Thiruvengadam R; Awasthi A; Medigeshi G; Bhattacharya S; Mani S; Sivasubbu S; Shrivastava T; Samal S; Rathna Murugesan D; Koundinya Desiraju B; Kshetrapal P; Pandey R; Scaria V; Kumar Malik P; Taneja J; Binayke A; Vohra T; Zaheer A; Rathore D; Ahmad Khan N; Shaman H; Ahmed S; Kumar R; Deshpande S; Subramani C; Wadhwa N; Gupta N; Pandey AK; Bhattacharya J; Agrawal A; Vrati S; Bhatnagar S; Garg PK;
Lancet Infect Dis; 2022 Apr; 22(4):473-482. PubMed ID: 34838183
[TBL] [Abstract][Full Text] [Related]
18. Comparison of characteristics, predictors and outcomes between the first and second COVID-19 waves in a tertiary care centre in Switzerland: an observational analysis.
Wolfisberg S; Gregoriano C; Struja T; Kutz A; Koch D; Bernasconi L; Hammerer-Lercher A; Mohr C; Haubitz S; Conen A; Fux C; Mueller B; Schuetz P
Swiss Med Wkly; 2021 Aug; 151():w20569. PubMed ID: 34375985
[TBL] [Abstract][Full Text] [Related]
19. Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study.
Schmidt M; Hajage D; Landoll M; Pequignot B; Langouet E; Amalric M; Mekontso-Dessap A; Chiscano-Camon L; Surman K; Finnerty D; Santa-Teresa P; Arcadipane A; Millán P; Roncon-Albuquerque R; Blandino-Ortiz A; Blanco-Schweizer P; Ricart P; Gimeno-Costa R; Albacete CL; Fortuna P; Schellongowski P; Dauwe D; Winiszewski H; Kimmoun A; Levy B; Hermans G; Grasselli G; Lebreton G; Guervilly C; Martucci G; Karagiannidis C; Riera J; Combes A;
Lancet Respir Med; 2023 Feb; 11(2):163-175. PubMed ID: 36640786
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348 691 UK users of the UK ZOE COVID Study app.
Visconti A; Murray B; Rossi N; Wolf J; Ourselin S; Spector TD; Freeman EE; Bataille V; Falchi M
Br J Dermatol; 2022 Dec; 187(6):900-908. PubMed ID: 35869671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
